Immunohistochemical investigation of hormone receptors and vascular endothelial growth factor concentration in vestibular schwannoma

Skull Base

Volumn 18, Issue 6, 2008, Pages 377-384

  Dalgorf, Dustin M ^a   Rowsell, Corwyn ^a   Bilbao, Juan M ^a   Chen, Joseph M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acoustic neuroma; Estrogen receptor; Immunohistochemistry; Progesterone receptor; Vascular endothelial growth factor; Vestibular schwannoma

Indexed keywords

ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; VASCULOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEURILEMOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VOLUME;

EID: 56649109728     PISSN: 15315010     EISSN: 15320065     Source Type: Journal    
DOI: 10.1055/s-0028-1096198     Document Type: Article

References (40)

1. van Leeuwen JPPM, Cremers CWRJ, Thewissen NPMW, Harhangi BS, Meijer E. Acoustic neuroma: correlation among tumour size, symptoms, and patient age. Laryngoscope 1995;105:701-707
2. Olivero WC, Lister JR, Elwood PW. The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 1995;83:222-224
3. Wazen J, Silverstein H, Norrell H, Besse B. Preoperative and postoperative growth rates in acoustic neuromas documented with CT scanning. Otolaryngol Head Neck Surg 1985;93:151-155
4. Silverstein H, McDaniel A, Norrell H, Wazen J. Conservative management of acoustic neuroma in the elderly patient. Laryngoscope 1985;95:766-770
5. Gardner G, Moretz WH, Robertson JH, Clark C, Shea JJ Jr. Non-surgical management of small and intracanalicular acoustic tumors. Otolaryngol Head Neck Surg 1986;94:328-333
6. Nedzelski JM, Canter RJ, Kassel EE, Rowed DW, Tator CH. Is no treatment good treatment in the management of acoustic neuromas in the elderly? Laryngoscope 1986;96:825-829
7. Nedzelski JM, Schessel DA, Pfleidera A, Kassel EE, Rowed DW. Conservative management of acoustic neuromas. Otolaryngol Clin North Am 1992;25:691-704
8. Lesser THJ, Janzer RC, Kleihues P, Fisch U. Clinical growth rate of acoustic schwannomas: correlation with the growth fraction as defined by the monoclonal antibody Ki-67. Skull Base Surg 1991;1:11-15
9. Strasnick B, Glasscock ME, Haynes D, McMenomey SO, Minor LB. The natural history of untreated acoustic neuromas. Laryngoscope 1994;104:1115-1119
10. Charabi S, Klinken L, Tos M, Thomsen J. Histopathology and growth pattern of cystic neuromas. Laryngoscope 1994;104:1348-1352
11. Charabi S, Mantoni M, Tos M, Thomsen J. Cystic vestibular schwannomas: neuroimaging and growth rate. J Laryngol Otol 1994;108:375-379
12. McGuire WL. Steroid receptors in breast cancer treatment strategy. Recent Prog Horm Res 1980;36:135-156
13. Valavaara R, Kangas L. The significance of estrogen receptors in tamoxifen and toremifene therapy. Ann Clin Res 1988;20:380-388
14. Rausing A, Ybo W, Stenflo J. Intracranial meningioma: a population study of ten years. Acta Neurol Scand 1970;46:102-110
15. Bickerstaff ER, Small JM, Guest IA. The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 1958;21:89-91
16. Kasantikul V, Netsky MG, Glassock ME III, Hays JW. Acoustic neurolemmoma: clinicoanatomical study of 103 patients. J Neurosurg 1980;52:28-35
17. Cayé-Thomasen P, Baandrup L, Jacobsen G, Thomsen J, Stangerup SE. Immunohistochemical demonstration of vascular endothelial growth factor in vestibular schwannomas correlates to tumor growth rate. Laryngoscope 2003;113:2129-2134
18. Cayé-Thomasen P, Werther K, Nalla A, et al. VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumour growth rate. Otol Neurotol 2005;26:98-101
19. Labit-Bouvier C, Crebassa B, Bouvier C, Andrac-Meyer L, Magnan J, Charpin C. Clinicopathologic growth factors in vestibular schwannomas: a morphological and immunohistochemical study of 69 tumours. Acta Otolaryngol 2000;120:950-954
20. Charabi S. Acoustic neuroma/vestibular schwannoma in vivo and in vitro growth models. A clinical and experimental study. Acta Otolaryngol Suppl 1997;530:1-27
21. Dutton JEM, Ramsden RT, Lye RH, et al. Acoustic neuroma (schwannoma) surgery. J Laryngol Otol 1991;105:165-173
22. Markwalder TM, Seiler RW, Zava DT. Antiestrogen therapy of meningioma - a pilot study. Surg Neurol 1985;24:245-249
23. Jaaskelainen J, Laasonen E, Karkkainen J, Haltia M, Troupp H. Hormone treatment of meningioma. Lack of response to medroxyprogesterone acetate (MPA). Acta Neurochir (Wien) 1986;80:35-41
24. Beatty CW, Scheithauer BW, Katzmann JA, Roche PC, Kjeldahl KS, Ebersold MJ. Acoustic schwannoma and pregnancy: a DNA flow cytometric, steroid hormone receptor, and proliferation marker study. Laryngoscope 1995;105:693-700
25. Chen JM, Houle S, Ang LC, et al. A study of vestibular schwannomas using positron emission tomography and monoclonal antibody Ki-67. Am J Otol 1998;19:840-845
26. Diensthuber M, Brandis A, Lenarz T, Stöver T. Co-expression of transforming growth factor β-1 and glial cell line-derived neurotrophic factor in vestibular schwannoma. Otol Neurotol 2004;25:359-365
27. O'Reilly BF, Kishore A, Crowther JA, Smith C. Correlation of growth factor receptor expression with clinical growth in vestibular schwannomas. Otol Neurotol 2004;25:791-796
28. Niemczyk K, Vaneecloo FM, Lecomte MH, et al. Correlation between Ki-67 index and some clinical aspects of acoustic neuromas (vestibular schwannomas). Otolaryngol Head Neck Surg 2000;123:779-783
29. i-67 and proliferating cell nuclear antigen. Am J Otol 1995; 16:616-619
30. Kasantikul V, Brown WJ. Estrogen receptors in acoustic neurilemmoma. Surg Neurol 1981;15:105-109
31. Martuza RL, MacLaughlin DT, Ojemann RG. Specific estradiol binding in schwannomas, meningiomas, and neurofibromas. Neurosurgery 1981;9:665-671
32. Wittliff JL. Steroid-hormone receptors in breast cancer. Cancer 1984;53:630-643
33. Monsell EM, Wiet RJ. Estrogen and progesterone binding by acoustic neuroma tissue. Otolaryngol Head Neck Surg 1990;103:377-379
34. Whittle IR, Hawkins RA, Miller JD. Sex hormone receptors in intracranial tumours and normal brain. Eur J Surg Oncol 1987;13:303-307
35. Siglock TJ, Rosenblatt SS, Finck F, House WF, Hitselberger WE. Sex hormone receptors in acoustic neuromas. Am J Otol 1990;11:237-239
36. Klinken L, Thomsen J, Rasmussen BB, Wiet R, Tos M. Estrogen and progesterone receptors in acoustic neuromas. Arch Otolaryngol Head Neck Surg 1990;116:202-204
37. Curley JWA, Ramsden RT, Howell A, Healy K, Lye RH. Oestrogen and progesterone receptors in acoustic neuroma. J Laryngol Otol 1990;104:865-867
38. Brieger J, Bedavanija A, Jans-Anton L, Maurer J, Mann W. Expression of angiogenic growth factors in acoustic neuroma. Acta Otolaryngol 2003;123:1040-1045
39. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993;362:841-844
40. Neff BA, Welling DB, Akhamametyeva E, Chang LS. The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level. Otol Neurotol 2006;27:197-208